About NextCure (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Through its Functional, Integrat... Read more
- USD1.58
- USD1.71
- USD1.55
- USD2.57
- 9.00%
- --
- 61.70k
- 242.32k
- 54M
- 0.98
- -1.30%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
